Steroid-free immunosuppression in kidney transplant recipients and prograf monotherapy: an interim analysis of a prospective multicenter trial.

@article{Bckman2006SteroidfreeII,
  title={Steroid-free immunosuppression in kidney transplant recipients and prograf monotherapy: an interim analysis of a prospective multicenter trial.},
  author={Lars A B{\"a}ckman and H Aselius and Kerstin Lindberger and Lars Georg Svensson and Ulf H. Str{\"o}mbom and Eva A Olausson and Henrik Hadimeri and S-I Deurell and Jonny Norrby and Markus G{\"a}bel and A Ebermark and Michael Olausson},
  journal={Transplantation proceedings},
  year={2006},
  volume={38 8},
  pages={2654-6}
}
This report described an interim analysis of a investigator-driven multicenter trial in renal transplant recipients: the Prospective Quality of life Renal Transplantation Switch Study; Tacrolimus-based immunosuppression ("PQRST study"). Patients included in the trial initially treated with cyclosporine-based immunosuppression after renal transplantation who experienced side effects, such as hypertension, hyperlipidemia, hypertrichosis, or other adverse reactions, were converted to a tacrolimus… CONTINUE READING